Which is better, CAH or COR?

On the Buffett-Fit framework, Cencora, Inc. (COR) currently grades higher than CAH — 51/100 (C grade) vs 32/100 (F). That said, "better" depends on which framework you trust — CAH wins on Philip Fisher and Joel Greenblatt; COR wins on Warren Buffett, Benjamin Graham, Peter Lynch, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy CAH or COR?

This page is an educational comparison, not investment advice. Both CAH and COR are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is CAH better than COR for value investing?

On the Buffett-style value-investing framework, COR currently grades higher — 51/100 vs 32/100, a 19-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between CAH and COR on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). CAH currently scores 32/100 (F grade); COR scores 51/100 (C grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, CAH or COR?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. CAH and COR are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, CAH or COR?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are CAH and COR both Healthcare stocks?

Yes — both Cardinal Health, Inc. (CAH) and Cencora, Inc. (COR) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this CAH vs COR comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Cardinal Health

Cencora

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

CAH

Cardinal Health

Market cap

$45.88B

Sector

Healthcare

COR

Cencora

Market cap

$51.35B

Sector

Healthcare

Overall winner

Cencora COR

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	CAH	COR	Winner
Warren Buffett	32F	51C	COR
Benjamin Graham	21F	69B	COR
Philip Fisher	42D	25F	CAH
Peter Lynch	43D	55C	COR
Joel Greenblatt	38D	32F	CAH
Charlie Munger	26F	38D	COR
Terry Smith	35D	41D	COR

Side-by-side metrics

Metric	CAH	COR
Market cap	$45.88B	$51.35B
P/E (TTM)	29.5x	20.1x
EV/EBIT	22.4x	16.9x
ROIC (TTM)	11.62%	11.89%
Gross margin	3.68%	3.47%
Net margin	0.62%	0.78%
Revenue CAGR 5y	8.19%	10.7%
EPS CAGR 5y	32.7%	1.76%
Debt / Equity	-	3.6x
Dividend yield	1.04%	0.89%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

CAH leads on

Debt / Equity-vs 3.6x+186%
EPS CAGR 5y32.7%vs 1.76%+95%
Dividend yield1.04%vs 0.89%+15%
Gross margin3.68%vs 3.47%+6%

COR leads on

P/E (TTM)20.1xvs 29.5x+32%
EV/EBIT16.9xvs 22.4x+25%
Revenue CAGR 5y10.7%vs 8.19%+23%
Net margin0.78%vs 0.62%+20%

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Cardinal Health

Cencora

Fit scores by strategy

Side-by-side metrics

Where each one wins

More like CAH

More like COR

Related on invest-like

Key terms in this analysis